default author photo

Michelle Arkin

University of California, San Francisco (UCSF)

SCHOLARLY PAPERS

2

DOWNLOADS

39

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

In Vivo Efficacy of ABHD17 Inhibition Validates the Palmitoylation Cycle as a Therapeutic Target in NRAS-Mutant Cancer

Number of pages: 42 Posted: 18 Apr 2026
University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), The Scripps Research Institute, University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), Lundbeck La Jolla Research Center Inc, Lundbeck La Jolla Research Center Inc, Lundbeck La Jolla Research Center Inc, Lundbeck La Jolla Research Center Inc, Lundbeck La Jolla Research Center Inc, Lundbeck La Jolla Research Center Inc, Lundbeck La Jolla Research Center Inc, Lundbeck La Jolla Research Center Inc, Indiana University - Center for Computational Biology and Bioinformatics, University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), Lundbeck La Jolla Research Center Inc, The Scripps Research Institute - Department of Chemistry, University of California, San Francisco (UCSF) and Independent
Downloads 21 (1,481,165)

Abstract:

Loading...

Ras, Acute myeloid leukemia, palmitoylation, melanoma, ABHD17

2.

WNK Inhibitors Acidify Lysosomes and Enhance Lysosomal Proteolytic Activity

Number of pages: 59 Posted: 13 May 2026
University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), University of California, San Francisco (UCSF), Eli Lilly and Company, Eli Lilly and Company, Eli Lilly and Company, University of California, San Francisco (UCSF), University of California, San Francisco (UCSF) and Independent
Downloads 18 (1,548,648)

Abstract:

Loading...

phenotypic screen, lysosomal pH, kinase inhibitors, WNK inhibition, neurodegeneration, aging, autophagy, lysosomal regulation, lysosomal proteolysis, Alzheimer's disease